Skip navigation
Skip navigation

Challenges for Australia's bio/nanopharma policies: trade deals, public goods and reference pricing in sustainable industrial renewal

Faunce, Thomas


Industrial renewal in the bio/nanopharma sector is important for the long term strength of the Australian economy and for the health of its citizens. A variety of factors, however, may have caused inadequate attention to focus on systematically promoting domestic generic and small biotechnology manufacturers in Australian health policy. Despite recent clarifications of 'springboarding' capacity in intellectual property legislation, federal government requirements for specific generic price...[Show more]

CollectionsANU Research Publications
Date published: 2007-06-01
Type: Journal article
Source: Australia and New Zealand Health Policy
DOI: 10.1186/1743-8462-4-9


File Description SizeFormat Image
Faunce_Challenges.pdf380.75 kBAdobe PDFThumbnail

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator